THE USE OF SGC STIMULATORS, SGC ACTIVATORS, ALONE AND COMBINATIONS WITH PDE5 INHIBITORS FOR THE TREATMENT OF DIGITAL ULCERS (DU) CONCOMITANT TO SYSTEMIC SCLEROSIS (SSC)

Number of patents in Portfolio can not be more than 2000

United States of America Patent

SERIAL NO

15571105

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Use of sGC stimulators, sGC activators alone, or in combination with PDE5 inhibitors for the prevention and healing of Digital Ulcers which are concomitant to fibrotic diseases, such as systemic sclerosis and scleroderma.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
BAYER PHARMA AKTIENGESELLSCHAFTMÜLLERSTRASSE 178 BERLIN 13353

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
FOLLMANN, Markus Köln, DE 77 838
HAHN, Michael Langenfeld, DE 178 1373
HIRTH-DIETRICH, Claudia Wuppertal, DE 40 270
SANDNER, Peter Wuppertal, DE 36 120
STASCH, Johannes-Peter Grottaferrata (RM), IT 206 3335
VAKALOPOULOS, Alexandros Hilden, DE 83 431

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation